$8 Million Verdict Against J&J in Massachusetts Talc-Mesothelioma Trial

In a significant legal blow to Johnson & Johnson, a Massachusetts jury has awarded $8 million in damages to Janice Paluzzi, a woman diagnosed with mesothelioma after decades of using the company’s talcum powder products. The verdict was delivered on June 24, 2025, in the case Paluzzi v. Johnson & Johnson by a Suffolk County jury.

Defective Design at the Core

Paluzzi, who was diagnosed with the rare and aggressive cancer in 2021, received $5 million for past pain and suffering and $3 million for future suffering. The jury concluded that J&J’s talc-based products, specifically Johnson’s Baby Powder and Shower to Shower, were defectively designed and that the defect was a substantial factor in causing her illness.

Notably, the jury found liability solely on the grounds of design defect. Claims for failure to warn and breach of implied warranty were rejected.

Defense Shifted Blame — Jury Didn’t Agree

J&J’s legal team, led by Bruce Hurley (King & Spalding) and Tara Blake (Kirkland & Ellis LLP), attempted to deflect liability by suggesting Paluzzi may have been exposed to asbestos through her three sons, who worked in maintenance at Boston’s John Hancock Building. But the jury sided with the plaintiff’s argument that the real danger lay in the talc products themselves.

Key to the case was expert testimony that criticized the industry’s longstanding asbestos testing methods. One standout witness, Steven Haber, testified that J&J and others had used outdated and unreliable detection techniques for decades and that internal documents showed J&J was aware of potential asbestos contamination as far back as the 1960s.

Legal Strategy and Impact

Paluzzi’s legal team, Braly and Aaron Chapman of Dean Omar Branham Shirley LLP, leaned heavily on scientific evidence and internal corporate records. The firm, based in Dallas, has successfully litigated similar cases in multiple states, including Connecticut, Illinois, South Carolina, and Oregon.

While J&J has already indicated its intent to appeal, calling the verdict “based on unsupported scientific claims driven by litigation funding interests”, the decision adds to the mounting legal pressure the company faces. Thousands of talc-related lawsuits remain pending across the country.

A Pivotal Chapter in Talc Litigation

This $8 million award marks yet another chapter in the protracted legal battle over J&J’s talc-based products and their alleged link to asbestos exposure and cancer. Although the company has sought bankruptcy protections and settlement mechanisms in past years, courtroom losses like this continue to erode its defense.

For now, the Massachusetts verdict reinforces a growing trend: juries are increasingly willing to side with plaintiffs when credible scientific evidence and internal corporate knowledge are brought to light.

Details were originally shared by Legal Claim Assistance via LinkedIn